The Center for Hyperhidrosis, a medical facility specializing in excessive sweating treatments, has acquired ...

In June 2024, the U.S. Food and Drug Administration (FDA) approved Sofdra™ (sofpironium bromide) topical gel, 12.45% for ...

Please provide your email address to receive an email when new articles are posted on . Candesant Biomedical announced positive results from its pilot study on the targeted alkali thermolysis patch, ...

QBREXZA is the first and only FDA-approved, once-daily, topical prescription treatment indicated for people 9 years of age and older with primary axillary hyperhidrosis, also known as excessive ...

Please provide your email address to receive an email when new articles are posted on . Sofdra (sofpironium) gel 12.45% is the first and only chemical entity for primary axillary hyperhidrosis. The ...

Hyperhidrosis most commonly affects the armpits, followed by the palms of the hands and the soles of the feet. Impairment of quality of life differs based on where primary hyperhidrosis manifests on ...

The US Food and Drug Administration (FDA) today cleared the first patch to reduce excessive underarm sweating for adults with primary axillary hyperhidrosis. The single-use, disposable, ...

"Axillary hyperhidrosis Pipeline 2025"DelveInsight's,“Axillary Hyperhidrosis - Pipeline Insight, 2025,” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Axillary ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The FDA approved ...

NASHVILLE, Tenn., March 18, 2023 /PRNewswire/ -- Candesant Biomedical ("Candesant"), a private medical device company focused on the development and commercialization of non-invasive treatments for ...

Daily treatment with sofpironium bromide gel was generally well-tolerated over 48 weeks of treatment Efficacy assessments showed a clinically meaningful and sustained improvement in sweat severity ...